nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—AR—type 2 diabetes mellitus	0.909	1	CbGaD
Nandrolone phenpropionate—Levonorgestrel—SRD5A1—type 2 diabetes mellitus	0.00164	0.18	CrCbGaD
Nandrolone phenpropionate—Etonogestrel—SHBG—type 2 diabetes mellitus	0.000786	0.086	CrCbGaD
Nandrolone phenpropionate—Nandrolone decanoate—AR—type 2 diabetes mellitus	0.000733	0.0802	CrCbGaD
Nandrolone phenpropionate—Norgestimate—ABCC2—type 2 diabetes mellitus	0.000708	0.0776	CrCbGaD
Nandrolone phenpropionate—Estradiol valerate/Dienogest—CYP3A4—type 2 diabetes mellitus	0.000662	0.0725	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000577	0.00704	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	0.00057	0.00695	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.000568	0.00694	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.000564	0.00688	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.000562	0.00686	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.000561	0.00684	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000558	0.00681	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—SHBG—type 2 diabetes mellitus	0.000556	0.0609	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.000555	0.00677	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—type 2 diabetes mellitus	0.00055	0.00671	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.000548	0.00669	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.000541	0.0066	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR3C1—type 2 diabetes mellitus	0.000527	0.00644	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PIK3R1—type 2 diabetes mellitus	0.000523	0.00639	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000517	0.00631	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HIF1A—type 2 diabetes mellitus	0.000513	0.00626	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—NR3C1—type 2 diabetes mellitus	0.000511	0.00624	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—type 2 diabetes mellitus	0.000506	0.00617	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000501	0.0549	CrCbGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000494	0.00603	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—AR—type 2 diabetes mellitus	0.000488	0.0534	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—type 2 diabetes mellitus	0.000468	0.00571	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000461	0.00562	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000456	0.00556	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—INS—type 2 diabetes mellitus	0.000451	0.0055	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—SHBG—type 2 diabetes mellitus	0.000451	0.0493	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000444	0.00542	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000415	0.00507	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000408	0.00499	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—SRC—type 2 diabetes mellitus	0.000387	0.00472	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000385	0.00469	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SIRT1—type 2 diabetes mellitus	0.000381	0.00465	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000375	0.00458	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—SRC—type 2 diabetes mellitus	0.000372	0.00454	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—type 2 diabetes mellitus	0.000364	0.00445	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000352	0.0386	CrCbGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CASP8—type 2 diabetes mellitus	0.000342	0.00417	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000336	0.0041	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000336	0.0041	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	0.000327	0.00399	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	0.000317	0.00387	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—MTR—type 2 diabetes mellitus	0.000306	0.00374	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000305	0.00372	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CDKN2A—type 2 diabetes mellitus	0.000298	0.00363	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000296	0.00362	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.000292	0.00357	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000289	0.00353	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000278	0.00339	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—CYP3A4—type 2 diabetes mellitus	0.000271	0.0297	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000269	0.00328	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000263	0.00321	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—SHBG—type 2 diabetes mellitus	0.000263	0.0287	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.00026	0.00318	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	0.000259	0.00316	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000254	0.0031	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000252	0.00308	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000251	0.00307	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000251	0.00307	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000249	0.00305	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—SHBG—type 2 diabetes mellitus	0.000248	0.0272	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000248	0.00303	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000245	0.00299	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000242	0.00295	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.000241	0.00295	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—type 2 diabetes mellitus	0.000241	0.00294	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—type 2 diabetes mellitus	0.00024	0.00293	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000239	0.00291	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000238	0.00291	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000236	0.00288	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AR—type 2 diabetes mellitus	0.000235	0.00287	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.000233	0.00284	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—type 2 diabetes mellitus	0.000231	0.00282	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—AR—type 2 diabetes mellitus	0.00023	0.0252	CrCbGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000225	0.00275	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.000224	0.00273	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—AR—type 2 diabetes mellitus	0.000218	0.0238	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000216	0.00263	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000215	0.00262	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RELA—type 2 diabetes mellitus	0.000212	0.00259	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000209	0.00255	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000207	0.00252	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000205	0.0025	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000203	0.00248	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.000199	0.00243	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—type 2 diabetes mellitus	0.000197	0.0024	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000196	0.0024	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—CYP3A4—type 2 diabetes mellitus	0.000192	0.021	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.00019	0.00232	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.00019	0.00232	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.00019	0.00232	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000185	0.00226	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000183	0.00223	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000178	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	0.000176	0.00214	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000175	0.00214	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.000172	0.00211	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.00017	0.00207	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SRC—type 2 diabetes mellitus	0.000166	0.00203	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000165	0.00202	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000163	0.00198	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—NR3C1—type 2 diabetes mellitus	0.000156	0.0171	CrCbGaD
Nandrolone phenpropionate—Norethindrone—CYP3A4—type 2 diabetes mellitus	0.000155	0.017	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	0.000151	0.00184	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—type 2 diabetes mellitus	0.000146	0.00178	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	0.000144	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.000144	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000142	0.00174	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000142	0.00173	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—BHMT—type 2 diabetes mellitus	0.000141	0.00173	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—type 2 diabetes mellitus	0.00014	0.00171	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000139	0.0017	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000137	0.00167	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP1A2—type 2 diabetes mellitus	0.000137	0.015	CrCbGaD
Nandrolone phenpropionate—Norethindrone—ALB—type 2 diabetes mellitus	0.000135	0.0148	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000135	0.00164	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000125	0.00153	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AANAT—type 2 diabetes mellitus	0.000124	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGDS—type 2 diabetes mellitus	0.000124	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000122	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000122	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000121	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000118	0.00144	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000118	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CDO1—type 2 diabetes mellitus	0.000117	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPD2—type 2 diabetes mellitus	0.000117	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000117	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NCOA6—type 2 diabetes mellitus	0.000115	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000115	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000114	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000114	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AK1—type 2 diabetes mellitus	0.000112	0.00136	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000112	0.00136	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	0.000112	0.00136	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000111	0.00135	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000108	0.00131	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000106	0.0013	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	0.000104	0.00127	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000104	0.00127	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000103	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—type 2 diabetes mellitus	0.000103	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000103	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000103	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000103	0.00125	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000101	0.00123	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000101	0.00123	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	9.99e-05	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.97e-05	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ND1—type 2 diabetes mellitus	9.97e-05	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ENPP1—type 2 diabetes mellitus	9.97e-05	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—G6PC—type 2 diabetes mellitus	9.97e-05	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HBA2—type 2 diabetes mellitus	9.97e-05	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	9.7e-05	0.00118	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCGR—type 2 diabetes mellitus	9.65e-05	0.00118	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	9.56e-05	0.00117	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	9.29e-05	0.00113	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	9.14e-05	0.00112	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	9.11e-05	0.00111	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—OXCT1—type 2 diabetes mellitus	9.11e-05	0.00111	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	9.11e-05	0.00111	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP3A4—type 2 diabetes mellitus	9.05e-05	0.00991	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	9.04e-05	0.0011	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	8.88e-05	0.00108	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	8.87e-05	0.00108	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	8.8e-05	0.00107	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP3A4—type 2 diabetes mellitus	8.56e-05	0.00937	CrCbGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	8.54e-05	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	8.47e-05	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	8.47e-05	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	8.47e-05	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	8.23e-05	0.001	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	8.12e-05	0.000992	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	8.12e-05	0.000992	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	8.08e-05	0.000986	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	7.92e-05	0.000967	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HNF4A—type 2 diabetes mellitus	7.82e-05	0.000955	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	7.82e-05	0.000954	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	7.82e-05	0.000954	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	7.68e-05	0.000938	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.68e-05	0.000937	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	7.55e-05	0.000922	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	7.55e-05	0.000922	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	7.55e-05	0.000922	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	7.54e-05	0.000921	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ALB—type 2 diabetes mellitus	7.46e-05	0.00817	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.32e-05	0.000894	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	7.16e-05	0.000874	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	7.1e-05	0.000867	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	7.06e-05	0.000861	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.99e-05	0.000853	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PSMD6—type 2 diabetes mellitus	6.84e-05	0.000835	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—DNMT1—type 2 diabetes mellitus	6.84e-05	0.000835	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.82e-05	0.000832	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	6.78e-05	0.000827	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CTGF—type 2 diabetes mellitus	6.71e-05	0.000819	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	6.65e-05	0.000812	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.64e-05	0.000811	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	6.42e-05	0.000784	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	6.42e-05	0.000784	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	6.42e-05	0.000784	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	6.42e-05	0.000784	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	6.36e-05	0.000776	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.17e-05	0.000754	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	6.16e-05	0.000751	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.98e-05	0.00073	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.86e-05	0.000715	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	5.83e-05	0.000712	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH2—type 2 diabetes mellitus	5.81e-05	0.00071	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.79e-05	0.000707	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	5.72e-05	0.000699	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.62e-05	0.000685	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	5.34e-05	0.000652	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	5.23e-05	0.000639	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	5.23e-05	0.000639	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	5.13e-05	0.000627	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.1e-05	0.000623	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	5.1e-05	0.000623	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	5.1e-05	0.000623	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	5.1e-05	0.000623	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.07e-05	0.000619	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CDKN2B—type 2 diabetes mellitus	5e-05	0.00061	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	4.98e-05	0.000608	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SIRT1—type 2 diabetes mellitus	4.94e-05	0.000603	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	4.92e-05	0.000601	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.59e-05	0.00056	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	4.58e-05	0.000558	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	4.58e-05	0.000558	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	4.58e-05	0.000558	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	4.49e-05	0.000548	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	4.45e-05	0.000543	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.39e-05	0.000536	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	4.39e-05	0.000535	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	4.37e-05	0.000533	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.36e-05	0.000532	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.18e-05	0.000511	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.14e-05	0.000505	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.14e-05	0.000505	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARA—type 2 diabetes mellitus	4.11e-05	0.000502	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.04e-05	0.000493	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.01e-05	0.00049	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.97e-05	0.000484	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	3.97e-05	0.000484	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	3.42e-05	0.000417	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.42e-05	0.000417	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	3.4e-05	0.000415	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARG—type 2 diabetes mellitus	3.4e-05	0.000415	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	3.36e-05	0.00041	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	3.26e-05	0.000398	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	3.17e-05	0.000387	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	3.11e-05	0.00038	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	3.06e-05	0.000374	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	3.05e-05	0.000372	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	3.04e-05	0.000371	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	2.96e-05	0.000361	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.92e-05	0.000357	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.8e-05	0.000342	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	2.75e-05	0.000336	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	2.66e-05	0.000325	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-05	0.00032	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	2.61e-05	0.000318	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-05	0.000315	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	2.27e-05	0.000277	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	2.23e-05	0.000272	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	2.04e-05	0.000249	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.95e-05	0.000239	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	1.95e-05	0.000239	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-05	0.000218	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—type 2 diabetes mellitus	1.34e-05	0.000164	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	8.99e-06	0.00011	CbGpPWpGaD
